Page last updated: 2024-12-08

marmesin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

marmesin: RN given refers to (S)-isomer; nodakenetin is the (R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID334704
CHEMBL ID442813
CHEBI ID6695
SCHEMBL ID12062107
MeSH IDM0041956

Synonyms (76)

Synonym
BRD-K36377456-001-02-0
DIVK1C_007014
SDCCGMLS-0066759.P001
7h-furo[3, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (s)-(+)-
marmesin, (+)-
nsc340840
7h-furo[3, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (+)-
s(+)-marmesin
nsc-340840
7h-furo[3, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (s)-
SPECTRUM_001516
SPECTRUM4_001701
ccris 5728
nsc 340840
7h-furo(3,2-g)(1)benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (s)-(+)-
(s)-marmesin
SPECTRUM5_000402
MEGXP0_001933
(s)-(+)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-7h-furo[3,2-g][1]benzopyran-7-one
(2s)-2-(1-hydroxy-1-methylethyl)-2,3-dihydro-7h-furo[3,2-g]chromen-7-one
(s)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-7h-furo[3,2-g][1]benzopyran-7-one
(+)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-7h-furo[3,2-g][1]benzopyran-7-one
(7s)-marmesin
CHEBI:6695 ,
s-(+)-marmesin
C09276
(+)-marmesin
(s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-7h-furo[3,2-g]chromen-7-one
13849-08-6
marmesin
BSPBIO_003363
KBIO2_007132
KBIO3_002583
KBIOGR_002022
KBIO1_001958
KBIO2_001996
KBIOSS_001996
KBIO2_004564
SPECTRUM2_000737
SPECTRUM3_001642
SPECPLUS_000918
SPBIO_000694
bdbm50250917
(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro[3,2-g]chromen-7-one
CHEMBL442813 ,
unii-h5d33d6k5d
h5d33d6k5d ,
hsdb 8478
S3283
CCG-40145
AB00053150-02
AKOS021983162
SCHEMBL12062107
AC-35105
2-(2-hydroxypropan-2-yl)-2h,3h,7h-furo[3,2-g]chromen-7-one
CS-7901
7h-furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (+)-
7h-furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (s)-(+)-
2-(1-hydroxy-1-methylethyl)-2,3-dihydro-7h-furo[3,2-g]chromen-7-one #
FWYSBEAFFPBAQU-LBPRGKRZSA-N
7h-furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (s)-
(2s)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-7h-furo[3,2-g][1]benzopyran-7-one
mfcd01725701
ncgc00178117-02!(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro[3,2-g]chromen-7-one
(s)-2-(2-hydroxypropan-2-yl)-2h-furo[3,2-g]chromen-7(3h)-one
7h-furo(3,2-g)(1)benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (2s)-
HY-N2176
marmesin ((+)-marmesin)
(+)-marmesin;(s)-marmesin
Q13847605
nsc-796156
nsc796156
MS-23486
7h-furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (2s)-
(2s)-2-(2-hydroxypropan-2-yl)-2h,3h,7h-furo[3,2-g]chromen-7-one
DTXSID001030448

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Marmesin treatment inhibited VEGF-A-stimulated endothelial cell proliferation through down-regulation of cell cycle-related proteins including cyclin-dependent kinases and cyclins, leading to pRb hypophosphorylation and G1 phase cell cycle arrest."( Marmesin is a novel angiogenesis inhibitor: Regulatory effect and molecular mechanism on endothelial cell fate and angiogenesis.
Ahn, EK; Bae, GU; Cho, YR; Kim, JH; Kim, JK; Kim, YK; Ko, HJ; Lee, CH; Oh, JS; Seo, DW, 2015
)
2.58

Dosage Studied

ExcerptRelevanceReference
" Remarkably, marmesin prevent tumor growth significantly in vivo at the dosage of 30 mg/kg in vivo."( In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial-mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
Bi, KH; Dong, L; Li, H; Xu, WW, 2018
)
1.11
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
marmesin
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
linear furanocoumarin biosynthesis221
Linear furanocoumarin biosynthesis015

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)67.00000.00000.933210.0000AID360659
Beta-secretase 1Homo sapiens (human)IC50 (µMol)500.00000.00061.619410.0000AID637774
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (30)

Processvia Protein(s)Taxonomy
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (29)

Processvia Protein(s)Taxonomy
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID354444Antiplasmodial activity against Plasmodium falciparum W22004Journal of natural products, Jan, Volume: 67, Issue:1
Syncarpamide, a new antiplasmodial (+)-norepinephrine derivative from Zanthoxylum syncarpum.
AID637774Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID354447Antifungal activity against Candida albicans B311 ATCC 90028 by antimicrobial susceptibility test2004Journal of natural products, Jan, Volume: 67, Issue:1
Syncarpamide, a new antiplasmodial (+)-norepinephrine derivative from Zanthoxylum syncarpum.
AID1072831Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID1072832Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID354448Antibacterial activity against Cryptococcus neoformans ATCC 90113 by antimicrobial susceptibility test2004Journal of natural products, Jan, Volume: 67, Issue:1
Syncarpamide, a new antiplasmodial (+)-norepinephrine derivative from Zanthoxylum syncarpum.
AID360659Inhibition of AChE by spectrophotometry2001Journal of natural products, May, Volume: 64, Issue:5
Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships.
AID354443Antiplasmodial activity against Plasmodium falciparum D62004Journal of natural products, Jan, Volume: 67, Issue:1
Syncarpamide, a new antiplasmodial (+)-norepinephrine derivative from Zanthoxylum syncarpum.
AID1072828Cytotoxicity against human 1A9 cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID354450Antibacterial activity against Staphylococcus aureus ATCC 33591 by antimicrobial susceptibility test2004Journal of natural products, Jan, Volume: 67, Issue:1
Syncarpamide, a new antiplasmodial (+)-norepinephrine derivative from Zanthoxylum syncarpum.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1072825Cytotoxicity against human SK-MEL-2 cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID354449Antibacterial activity against Staphylococcus aureus ATCC 6535 by antimicrobial susceptibility test2004Journal of natural products, Jan, Volume: 67, Issue:1
Syncarpamide, a new antiplasmodial (+)-norepinephrine derivative from Zanthoxylum syncarpum.
AID1072827Cytotoxicity against human CAKI-1 cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID637775Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID357965Inhibition of aromatase from human placental microsomes2001Journal of natural products, Oct, Volume: 64, Issue:10
Aromatase inhibitors from Broussonetia papyrifera.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1072833Cytotoxicity against human KBVIN cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID1072829Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by SRB assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (22.58)18.7374
1990's1 (3.23)18.2507
2000's8 (25.81)29.6817
2010's11 (35.48)24.3611
2020's4 (12.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.03 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (96.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]